StartUp Health NOW
Sami Inkinen of Virta Health on AI-Native Healthcare and Reversing Metabolic Disease
StartUp Health NOW
•February 13, 2026•21 min
0
StartUp Health NOW•Feb 13, 2026
Why It Matters
Reversing metabolic disease shifts healthcare from chronic management to curative care, promising massive cost savings and improved quality of life. Understanding how AI can operationalize personalized nutrition therapy offers founders and clinicians a roadmap for building scalable, data‑driven health solutions that address one of the world’s biggest public‑health challenges.
Key Takeaways
- •Virta uses AI to personalize metabolic disease reversal
- •AI‑native culture required for hiring and board decisions
- •Nutrition, not drugs, drives type‑2 diabetes reversal
- •Virta achieved 75% YoY growth, reached breakeven
- •CEO prioritizes AI first, generates ideas before analysis
Pulse Analysis
In this Startup Health Now episode, Sami Inkinen, CEO of Virta Health, explains how the company has woven artificial intelligence into every layer of its operation. From back‑office processes to front‑line patient interactions, AI‑natification is a board‑level priority, with every new hire tested on AI fluency. This AI‑first mindset enables Virta to mine the world’s largest longitudinal biomarker database, creating autonomous agents that continuously adjust nutrition‑based treatment plans for each patient. By treating food as therapy and leveraging AI’s pattern‑recognition power, Virta can deliver individualized interventions that would be impossible to scale manually.
Inkinen also highlights the business impact of this technology‑driven model. Virta’s AI‑enhanced platform has helped reverse type‑2 diabetes and obesity for hundreds of thousands of users, translating clinical success into rapid financial growth—75% year‑over‑year revenue increase and a recent breakeven milestone. The company argues that the conventional “insulin‑first” approach is outdated; instead, nutrition‑centric care, validated by AI‑derived insights, reduces complications such as heart attacks and strokes. This data‑backed narrative not only attracts investors but also fuels a brand loyalty so strong that patients have tattooed the Virta logo on their bodies.
Looking ahead, Inkinen advises founders that AI is now a table‑stake for any venture seeking funding, and existing companies must integrate AI purposefully, not as a gimmick. He predicts exponential advances in AI capabilities over the next two years, likening the upcoming wave to the iPhone’s impact on everyday tech. For Virta, the focus remains on scaling its AI‑powered metabolic health solution while shaping broader industry awareness that nutrition, empowered by intelligent software, is the true antidote to the global metabolic disease epidemic.
Episode Description
In this Apollo House 2026 fireside chat, StartUp Health community member Sami Inkinen, CEO & Founder of Virta Health, shares how a personal diagnosis of pre-diabetes led him to build one of the fastest-growing companies in metabolic health.
Virta Health is proving that Type 2 diabetes and obesity can be reversed with nutrition, supported by technology and AI. Inkinen discusses how Virta has built one of the largest longitudinal biomarker datasets in metabolic disease reversal and is deploying AI agents, supervised by clinicians, to support patients every day.
He offers blunt insight into the current standard of care, explains why he believes disease reversal must become the common-sense approach, and shares how Virta became AI-native across every function, from hiring to board strategy.
This episode covers:
• The future of AI in healthcare operations and patient care
As a live recording, the audio reflects the energy of the room rather than a studio setting.
Do you want to participate in live conversations with industry luminaries? When you join StartUp Health – a private community for founders, investors, buyers, and industry leaders to connect year-round – you are invited to a full calendar of interactive Fireside Chats with the most influential leaders shaping health innovation. Come with questions, learn what is working right now, and connect with industry icons.
» Learn more and join today.
Show Notes
Audio Player
Podcast: Play in new window | Download (Duration: 21:28 — 19.7MB)
Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More
In this Apollo House 2026 fireside chat, StartUp Health community member Sami Inkinen, CEO & Founder of Virta Health, shares how a personal diagnosis of pre-diabetes led him to build one of the fastest-growing companies in metabolic health.
Virta Health is proving that Type 2 diabetes and obesity can be reversed with nutrition, supported by technology and AI. Inkinen discusses how Virta has built one of the largest longitudinal biomarker datasets in metabolic disease reversal and is deploying AI agents, supervised by clinicians, to support patients every day.
He offers blunt insight into the current standard of care, explains why he believes disease reversal must become the common-sense approach, and shares how Virta became AI-native across every function, from hiring to board strategy.
This episode covers:
• The future of AI in healthcare operations and patient care
• Why food as therapy creates a complex, software-driven challenge
• The tension between GLP-1 drugs and root-cause treatment
• Scaling a B2B2C healthcare company to sustainability
• Advice for founders building in the age of AI
As a live recording, the audio reflects the energy of the room rather than a studio setting.
**Do you want to participate in live conversations with industry luminaries?**When you join StartUp Health– a private community for founders, investors, buyers, and industry leaders to connect year-round – you are invited to a full calendar of interactive Fireside Chats with the most influential leaders shaping health innovation. Come with questions, learn what is working right now, and connect with industry icons. »Learn more and join today.
0
Comments
Want to join the conversation?
Loading comments...